Porter, David A
6317  Ergebnisse:
Personensuche X
?
1

Water Markets: Institutions, Issues and Remedies:

, In: Elgar Encyclopedia of Water Policy, Economics and Management,
Zhao, Hao ; Porter, David ; Rassenti, Stephen - p. 352-356 , 2024
 
?
2

Preconditioning Frailty Phenotype Influences Survival and R..:

Sung, Anthony D. ; Koll, Thuy ; Gier, Shannon H....
Transplantation and Cellular Therapy.  30 (2024)  4 - p. 415.e1-415.e16 , 2024
 
?
3

Liposome-enabled bufalin and doxorubicin combination therap..:

Gao, Yu ; Shelling, Andrew N. ; Nolan, Emma...
Journal of Liposome Research.  34 (2024)  3 - p. 489-506 , 2024
 
?
4

If They RECUR, You Should Refer: A Community Oncologist Pat..:

Riedell, Peter A. ; Downs, Christian ; Boehmer, Leigh...
Transplantation and Cellular Therapy.  30 (2024)  1 - p. 14-16 , 2024
 
?
6

Designing agile pathways for climate adaptation skill devel..:

Porter, David ; Cox, Robin ; Forssman, Vivian
The Open/Technology in Education, Society, and Scholarship Association Journal.  3 (2024)  2 - p. 1-17 , 2024
 
?
8

Past and Future Reflections and Profiles of a Pioneer:

Porter, David L ; Korngold, Robert
Transplantation and Cellular Therapy.  30 (2024)  1 - p. 1-2 , 2024
 
?
9

Post-Transplant Frailty Phenotype Predicts Survival:

Hadjis, Ashley D. ; White, Griffin W. ; Gill, Saar I....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S407-S408 , 2024
 
?
12

Interim Results of a Phase I/II Trial of Intermediate-Dose ..:

McCurdy, Shannon R. ; Hyder, Mustafa A. ; Sabina, Ruby...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S2-S3 , 2024
 
?
 
?
14

Interim Results of a Phase I/II Study of Intermediate-Dose ..:

Hyder, Mustafa A. ; McCurdy, Shannon R. ; Sabina, Ruby...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S284-S285 , 2024
 
?
 
1-15